IL22 and colitis: A similar strategy has also been used for IL-22 delivery, with IL-22-encoding plasmids loaded on pH-responsive nanoparticles and orally delivered for local desensitization release in the colon, resulting in efficient repair of the intestinal epithelium and significant improvement in pathological scores in a mouse model of colitis (Qu et al., 2023).